Exploratory Study to Assess the Pharmacokinetics of AZD5985

NCT00799331 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: AZD5985
DRUG: placebo

Sponsor

AstraZeneca